Moderna Inc plans to price its experimental coronavirus vaccine in a way that ensures broad access, it said on Wednesday, adding that it did not intend to conduct latestage trials of the shot outside the United States. from Top Business News- News18.com Read The Rest:timesnownews...
No comments: